1
|
Compton ZT, Mellon W, Harris V, Rupp S, Mallo D, Kapsetaki S, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau MT, Duke E, Spiro S, Flach E, Davidson H, Li C, Zehnder A, Graham TA, Troan B, Harrison T, Tollis M, Schiffman J, Aktipis A, Abegglen L, Maley C, Boddy A. Cancer Prevalence Across Vertebrates. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2023.02.15.527881. [PMID: 36824942 PMCID: PMC9948983 DOI: 10.1101/2023.02.15.527881] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Cancer is pervasive across multicellular species, but what explains differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades (amphibians, sauropsids and mammals) we found that neoplasia and malignancy prevalence increases with adult weight (contrary to Petos Paradox) and somatic mutation rate, but decreases with gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%) the black-footed penguin (<0.4%), ferrets (63%) and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and prevention of cancer.
Collapse
|
2
|
Derényi I, Demeter MC, Pérez-Jiménez M, Grajzel D, Szöllősi GJ. How mutation accumulation depends on the structure of the cell lineage tree. Phys Rev E 2024; 109:044407. [PMID: 38755817 DOI: 10.1103/physreve.109.044407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Accepted: 03/08/2024] [Indexed: 05/18/2024]
Abstract
All the cells of a multicellular organism are the product of cell divisions that trace out a single binary tree, the so-called cell lineage tree. Because cell divisions are accompanied by replication errors, the shape of the cell lineage tree is a key determinant of how somatic evolution, which can potentially lead to cancer, proceeds. Carcinogenesis requires the accumulation of a certain number of driver mutations. By mapping the accumulation of mutations into a graph theoretical problem, we present an exact numerical method to calculate the probability of collecting a given number of mutations and show that for low mutation rates it can be approximated with a simple analytical formula, which depends only on the distribution of the lineage lengths, and is dominated by the longest lineages. Our results are crucial in understanding how natural selection can shape the cell lineage trees of multicellular organisms and curtail somatic evolution.
Collapse
Affiliation(s)
- Imre Derényi
- ELTE Eötvös University, Department of Biological Physics, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary and MTA-ELTE Statistical and Biological Physics Research Group, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary
| | - Márton C Demeter
- ELTE Eötvös University, Department of Biological Physics, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary and MTA-ELTE "Lendület" Evolutionary Genomics Research Group, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary
| | - Mario Pérez-Jiménez
- ELTE Eötvös University, Department of Biological Physics, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary and MTA-ELTE "Lendület" Evolutionary Genomics Research Group, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary
| | - Dániel Grajzel
- ELTE Eötvös University, Department of Biological Physics, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary and MTA-ELTE "Lendület" Evolutionary Genomics Research Group, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary
| | - Gergely J Szöllősi
- ELTE Eötvös University, Department of Biological Physics, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary; MTA-ELTE "Lendület" Evolutionary Genomics Research Group, Pázmány Péter Sétány 1A, H-1117 Budapest, Hungary; HUN-REN Centre for Ecological Research, Institute of Evolution, H-1113 Budapest, Hungary; and Model-Based Evolutionary Genomics Unit, Okinawa Institute of Science and Technology Graduate University, 904-0412 Okinawa, Japan
| |
Collapse
|
3
|
Pagano L, Thibault G, Bousselham W, Riesterer JL, Song X, Gray JW. Efficient semi-supervised semantic segmentation of electron microscopy cancer images with sparse annotations. FRONTIERS IN BIOINFORMATICS 2023; 3:1308707. [PMID: 38162122 PMCID: PMC10757843 DOI: 10.3389/fbinf.2023.1308707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Accepted: 11/29/2023] [Indexed: 01/03/2024] Open
Abstract
Electron microscopy (EM) enables imaging at a resolution of nanometers and can shed light on how cancer evolves to develop resistance to therapy. Acquiring these images has become a routine task.However, analyzing them is now a bottleneck, as manual structure identification is very time-consuming and can take up to several months for a single sample. Deep learning approaches offer a suitable solution to speed up the analysis. In this work, we present a study of several state-of-the-art deep learning models for the task of segmenting nuclei and nucleoli in volumes from tumor biopsies. We compared previous results obtained with the ResUNet architecture to the more recent UNet++, FracTALResNet, SenFormer, and CEECNet models. In addition, we explored the utilization of unlabeled images through semi-supervised learning with Cross Pseudo Supervision. We have trained and evaluated all of the models on sparse manual labels from three fully annotated in-house datasets that we have made available on demand, demonstrating improvements in terms of 3D Dice score. From the analysis of these results, we drew conclusions on the relative gains of using more complex models, and semi-supervised learning as well as the next steps for the mitigation of the manual segmentation bottleneck.
Collapse
Affiliation(s)
- Lucas Pagano
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, United States
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States
| | - Guillaume Thibault
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, United States
| | - Walid Bousselham
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, United States
| | - Jessica L. Riesterer
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, United States
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States
| | - Xubo Song
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, United States
- Department of Medical Informatics and Clinical Epidemiology at Oregon Health and Science University, Portland, OR, United States
| | - Joe W. Gray
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, United States
| |
Collapse
|
4
|
Pagano L, Thibault G, Bousselham W, Riesterer JL, Song X, Gray JW. Efficient semi-supervised semantic segmentation of electron microscopy cancer images with sparse annotations. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.10.30.563998. [PMID: 37961180 PMCID: PMC10635003 DOI: 10.1101/2023.10.30.563998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2023]
Abstract
Electron microscopy (EM) enables imaging at nanometer resolution and can shed light on how cancer evolves to develop resistance to therapy. Acquiring these images has become a routine task; however, analyzing them is now the bottleneck, as manual structure identification is very time-consuming and can take up to several months for a single sample. Deep learning approaches offer a suitable solution to speed up the analysis. In this work, we present a study of several state-of-the-art deep learning models for the task of segmenting nuclei and nucleoli in volumes from tumor biopsies. We compared previous results obtained with the ResUNet architecture to the more recent UNet++, FracTALResNet, SenFormer, and CEECNet models. In addition, we explored the utilization of unlabeled images through semi-supervised learning with Cross Pseudo Supervision. We have trained and evaluated all of the models on sparse manual labels from three fully annotated in-house datasets that we have made available on demand, demonstrating improvements in terms of 3D Dice score. From the analysis of these results, we drew conclusions on the relative gains of using more complex models, semi-supervised learning as well as next steps for the mitigation of the manual segmentation bottleneck.
Collapse
Affiliation(s)
- Lucas Pagano
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
| | - Guillaume Thibault
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
| | - Walid Bousselham
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
| | - Jessica L. Riesterer
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
| | - Xubo Song
- Department of Medical Informatics and Clinical Epidemiology at Oregon Health and Science University, Portland, OR USA
- Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA
| | - Joe W. Gray
- Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR, USA
| |
Collapse
|
5
|
Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Cancer Prevalence Across Vertebrates. RESEARCH SQUARE 2023:rs.3.rs-3117313. [PMID: 37461608 PMCID: PMC10350200 DOI: 10.21203/rs.3.rs-3117313/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/28/2023]
Abstract
Cancer is pervasive across multicellular species, but what explains differences in cancer prevalence across species? Using 16,049 necropsy records for 292 species spanning three clades (amphibians, sauropsids and mammals) we found that neoplasia and malignancy prevalence increases with adult weight (contrary to Peto's Paradox) and somatic mutation rate, but decreases with gestation time. Evolution of cancer susceptibility appears to have undergone sudden shifts followed by stabilizing selection. Outliers for neoplasia prevalence include the common porpoise (<1.3%), the Rodrigues fruit bat (<1.6%) the black-footed penguin (<0.4%), ferrets (63%) and opossums (35%). Discovering why some species have particularly high or low levels of cancer may lead to a better understanding of cancer syndromes and novel strategies for the management and prevention of cancer.
Collapse
Affiliation(s)
- Zachary T. Compton
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- School of Life Sciences, Arizona State University, Tempe, AZ
| | - Valerie Harris
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Walker Mellon
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Shawn Rupp
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Diego Mallo
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Stefania E. Kapsetaki
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Mallory Wilmot
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - Ryan Kennington
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - Kathleen Noble
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - Cristina Baciu
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- Department of Psychology, Arizona State University, Tempe, AZ
| | - Lucia Ramirez
- Genomic Sciences Graduate Program, North Carolina State University, Raleigh, NC
| | - Ashley Peraza
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Brian Martins
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Sushil Sudhakar
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Selin Aksoy
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
| | - Gabriella Furukawa
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
| | - Orsolya Vincze
- Institute of Aquatic Ecology, Centre for Ecological Research, 4026 Debrecen, Hungary
- Evolutionary Ecology Group, Hungarian Department of Biology and Ecology, Babeş-Bolyai University, 400006 Cluj-Napoca, Romania
| | | | - Elizabeth G. Duke
- North Carolina State College of Veterinary Medicine, Raleigh, NC
- Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC
| | - Simon Spiro
- Wildlife Health Services, Zoological Society of London, London, UK
| | - Edmund Flach
- Wildlife Health Services, Zoological Society of London, London, UK
| | - Hannah Davidson
- North Carolina State College of Veterinary Medicine, Raleigh, NC
- Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC
| | - Ashley Zehnder
- Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC
| | - Trevor A. Graham
- Centre for Evolution and Cancer, Institute of Cancer Research, London, UK
| | - Brigid Troan
- North Carolina State College of Veterinary Medicine, Raleigh, NC
- Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC
- The North Carolina Zoo, Asheboro, NC
| | - Tara M. Harrison
- North Carolina State College of Veterinary Medicine, Raleigh, NC
- Exotic Species Cancer Research Alliance, North Carolina State College of Veterinary Medicine, Raleigh, NC
| | - Marc Tollis
- School of Informatics, Computing and Cyber Systems, Northern Arizona University, Flagstaff, AZ
| | - Joshua D. Schiffman
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
- Peel Therapeutics, Inc., Salt Lake City, UT
| | - Athena Aktipis
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- Department of Psychology, Arizona State University, Tempe, AZ
| | - Lisa M. Abegglen
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
- Peel Therapeutics, Inc., Salt Lake City, UT
| | - Carlo C. Maley
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- School of Life Sciences, Arizona State University, Tempe, AZ
- Biodesign Center for Biocomputing, Security and Society, Arizona State University, Tempe, AZ
| | - Amy M. Boddy
- Arizona Cancer Evolution Center, The Biodesign Institute, Arizona State University, Tempe, AZ
- University of California Santa Barbara, Santa Barbara, CA
| |
Collapse
|
6
|
AbdulJabbar K, Castillo SP, Hughes K, Davidson H, Boddy AM, Abegglen LM, Minoli L, Iussich S, Murchison EP, Graham TA, Spiro S, Maley CC, Aresu L, Palmieri C, Yuan Y. Bridging clinic and wildlife care with AI-powered pan-species computational pathology. Nat Commun 2023; 14:2408. [PMID: 37100774 PMCID: PMC10133243 DOI: 10.1038/s41467-023-37879-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 04/04/2023] [Indexed: 04/28/2023] Open
Abstract
Cancers occur across species. Understanding what is consistent and varies across species can provide new insights into cancer initiation and evolution, with significant implications for animal welfare and wildlife conservation. We build a pan-species cancer digital pathology atlas (panspecies.ai) and conduct a pan-species study of computational comparative pathology using a supervised convolutional neural network algorithm trained on human samples. The artificial intelligence algorithm achieves high accuracy in measuring immune response through single-cell classification for two transmissible cancers (canine transmissible venereal tumour, 0.94; Tasmanian devil facial tumour disease, 0.88). In 18 other vertebrate species (mammalia = 11, reptilia = 4, aves = 2, and amphibia = 1), accuracy (range 0.57-0.94) is influenced by cell morphological similarity preserved across different taxonomic groups, tumour sites, and variations in the immune compartment. Furthermore, a spatial immune score based on artificial intelligence and spatial statistics is associated with prognosis in canine melanoma and prostate tumours. A metric, named morphospace overlap, is developed to guide veterinary pathologists towards rational deployment of this technology on new samples. This study provides the foundation and guidelines for transferring artificial intelligence technologies to veterinary pathology based on understanding of morphological conservation, which could vastly accelerate developments in veterinary medicine and comparative oncology.
Collapse
Affiliation(s)
- Khalid AbdulJabbar
- Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - Simon P Castillo
- Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK
| | - Katherine Hughes
- Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, UK
| | - Hannah Davidson
- Zoological Society of London, London, UK
- Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK
| | - Amy M Boddy
- Department of Anthropology, University of California Santa Barbara, Santa Barbara, CA, USA
| | - Lisa M Abegglen
- Department of Pediatrics and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
- PEEL Therapeutics, Inc., Salt Lake City, UT, USA
| | - Lucia Minoli
- Department of Veterinary Sciences, University of Turin, 10095, Grugliasco, Italy
| | - Selina Iussich
- Department of Veterinary Sciences, University of Turin, 10095, Grugliasco, Italy
| | - Elizabeth P Murchison
- Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, UK
| | - Trevor A Graham
- Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK
- Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Sq, London, UK
| | | | - Carlo C Maley
- Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Luca Aresu
- Department of Veterinary Sciences, University of Turin, 10095, Grugliasco, Italy
| | - Chiara Palmieri
- School of Veterinary Science, The University of Queensland, 4343, Gatton, QLD, Australia
| | - Yinyin Yuan
- Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
- Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
| |
Collapse
|
7
|
Wolf M, Zapf K, Gupta DK, Hiller M, Árnason Ú, Janke A. The genome of the pygmy right whale illuminates the evolution of rorquals. BMC Biol 2023; 21:79. [PMID: 37041515 PMCID: PMC10091562 DOI: 10.1186/s12915-023-01579-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2022] [Accepted: 03/27/2023] [Indexed: 04/13/2023] Open
Abstract
BACKGROUND Baleen whales are a clade of gigantic and highly specialized marine mammals. Their genomes have been used to investigate their complex evolutionary history and to decipher the molecular mechanisms that allowed them to reach these dimensions. However, many unanswered questions remain, especially about the early radiation of rorquals and how cancer resistance interplays with their huge number of cells. The pygmy right whale is the smallest and most elusive among the baleen whales. It reaches only a fraction of the body length compared to its relatives and it is the only living member of an otherwise extinct family. This placement makes the pygmy right whale genome an interesting target to update the complex phylogenetic past of baleen whales, because it splits up an otherwise long branch that leads to the radiation of rorquals. Apart from that, genomic data of this species might help to investigate cancer resistance in large whales, since these mechanisms are not as important for the pygmy right whale as in other giant rorquals and right whales. RESULTS Here, we present a first de novo genome of the species and test its potential in phylogenomics and cancer research. To do so, we constructed a multi-species coalescent tree from fragments of a whole-genome alignment and quantified the amount of introgression in the early evolution of rorquals. Furthermore, a genome-wide comparison of selection rates between large and small-bodied baleen whales revealed a small set of conserved candidate genes with potential connections to cancer resistance. CONCLUSIONS Our results suggest that the evolution of rorquals is best described as a hard polytomy with a rapid radiation and high levels of introgression. The lack of shared positive selected genes between different large-bodied whale species supports a previously proposed convergent evolution of gigantism and hence cancer resistance in baleen whales.
Collapse
Affiliation(s)
- Magnus Wolf
- Senckenberg Biodiversity and Climate Research Centre (BiK-F), Georg-Voigt-Strasse 14-16, Frankfurt Am Main, Germany
- Institute for Ecology, Evolution and Diversity, Goethe University, Max-Von-Laue-Strasse. 9, Frankfurt Am Main, Germany
| | - Konstantin Zapf
- Senckenberg Biodiversity and Climate Research Centre (BiK-F), Georg-Voigt-Strasse 14-16, Frankfurt Am Main, Germany
- Institute for Ecology, Evolution and Diversity, Goethe University, Max-Von-Laue-Strasse. 9, Frankfurt Am Main, Germany
| | - Deepak Kumar Gupta
- LOEWE-Centre for Translational Biodiversity Genomics (TBG), Senckenberg Nature Research Society, Georg-Voigt-Straße 14-16, Frankfurt Am Main, Germany
| | - Michael Hiller
- Senckenberg Biodiversity and Climate Research Centre (BiK-F), Georg-Voigt-Strasse 14-16, Frankfurt Am Main, Germany
- LOEWE-Centre for Translational Biodiversity Genomics (TBG), Senckenberg Nature Research Society, Georg-Voigt-Straße 14-16, Frankfurt Am Main, Germany
- Institute of Cell Biology and Neuroscience, Goethe University Frankfurt, Max-Von-Laue-Str. 9, Frankfurt Am Main, Germany
| | - Úlfur Árnason
- Department of Clinical Sciences Lund, Lund University, Lund, Sweden
- Department of Neurosurgery, Skane University Hospital in Lund, Lund, Sweden
| | - Axel Janke
- Senckenberg Biodiversity and Climate Research Centre (BiK-F), Georg-Voigt-Strasse 14-16, Frankfurt Am Main, Germany
- Institute for Ecology, Evolution and Diversity, Goethe University, Max-Von-Laue-Strasse. 9, Frankfurt Am Main, Germany
- LOEWE-Centre for Translational Biodiversity Genomics (TBG), Senckenberg Nature Research Society, Georg-Voigt-Straße 14-16, Frankfurt Am Main, Germany
| |
Collapse
|
8
|
Pavličev M, Wagner GP. The value of broad taxonomic comparisons in evolutionary medicine: Disease is not a trait but a
state of a trait
! MedComm (Beijing) 2022; 3:e174. [PMID: 36186235 PMCID: PMC9495303 DOI: 10.1002/mco2.174] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Revised: 08/12/2022] [Accepted: 08/21/2022] [Indexed: 11/09/2022] Open
Affiliation(s)
- Mihaela Pavličev
- Department of Evolutionary Biology University of Vienna Vienna Austria
| | - Günter P. Wagner
- Department of Ecology and Evolutionary Biology Yale University New Haven Connecticut USA
- Yale Systems Biology Institute Yale University West Haven Connecticut USA
- Department of Obstetrics Gynecology and Reproductive Sciences Yale School of Medicine New Haven Connecticut USA
- Department of Obstetrics and Gynecology Wayne State University Detroit Michigan USA
| |
Collapse
|
9
|
Ujvari B, Raven N, Madsen T, Klaassen M, Dujon AM, Schultz AG, Nunney L, Lemaître J, Giraudeau M, Thomas F. Telomeres, the loop tying cancer to organismal life-histories. Mol Ecol 2022; 31:6273-6285. [PMID: 35510763 PMCID: PMC9790343 DOI: 10.1111/mec.16488] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Revised: 03/04/2022] [Accepted: 03/30/2022] [Indexed: 01/31/2023]
Abstract
Recent developments in telomere and cancer evolutionary ecology demonstrate a very complex relationship between the need of tissue repair and controlling the emergence of abnormally proliferating cells. The trade-off is balanced by natural and sexual selection and mediated via both intrinsic and environmental factors. Here, we explore the effects of telomere-cancer dynamics on life history traits and strategies as well as on the cumulative effects of genetic and environmental factors. We show that telomere-cancer dynamics constitute an incredibly complex and multifaceted process. From research to date, it appears that the relationship between telomere length and cancer risk is likely nonlinear with good evidence that both (too) long and (too) short telomeres can be associated with increased cancer risk. The ability and propensity of organisms to respond to the interplay of telomere dynamics and oncogenic processes, depends on the combination of its tissue environments, life history strategies, environmental challenges (i.e., extreme climatic conditions), pressure by predators and pollution, as well as its evolutionary history. Consequently, precise interpretation of telomere-cancer dynamics requires integrative and multidisciplinary approaches. Finally, incorporating information on telomere dynamics and the expression of tumour suppressor genes and oncogenes could potentially provide the synergistic overview that could lay the foundations to study telomere-cancer dynamics at ecosystem levels.
Collapse
Affiliation(s)
- Beata Ujvari
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Nynke Raven
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Thomas Madsen
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Marcel Klaassen
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Antoine M. Dujon
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Aaron G. Schultz
- Centre for Integrative EcologySchool of Life and Environmental SciencesDeakin UniversityGeelongVictoriaAustralia
| | - Leonard Nunney
- Department of Evolution, Ecology and Organismal BiologyUniversity of California, RiversideRiversideCaliforniaUSA
| | - Jean‐François Lemaître
- Université de LyonLyonFrance,Laboratoire de Biométrie et Biologie ÉvolutiveUniversité Lyon 1CNRSUMR5558VilleurbanneFrance
| | - Mathieu Giraudeau
- CREEC/CANECEV (CREES)MIVEGECUnité Mixte de RecherchesIRD 224–CNRS 5290–Université de MontpellierMontpellierFrance,LIENSsUMR 7266 CNRS‐La Rochelle UniversitéLa RochelleFrance
| | - Frédéric Thomas
- CREEC/CANECEV (CREES)MIVEGECUnité Mixte de RecherchesIRD 224–CNRS 5290–Université de MontpellierMontpellierFrance
| |
Collapse
|
10
|
Baines C, Meitern R, Kreitsberg R, Sepp T. Comparative study of the evolution of cancer gene duplications across fish. Evol Appl 2022; 15:1834-1845. [PMID: 36426117 PMCID: PMC9679246 DOI: 10.1111/eva.13481] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Revised: 09/05/2022] [Accepted: 09/07/2022] [Indexed: 12/04/2022] Open
Abstract
Comparative studies of cancer‐related genes not only provide novel information about their evolution and function but also an understanding of cancer as a driving force in biological systems and species’ life histories. So far, these studies have focused on mammals. Here, we provide the first comparative study of cancer‐related gene copy number variation in fish. Fishes are a paraphyletic group whose last common ancestor is also an ancestor of the tetrapods, and accordingly, their tumour suppression mechanisms should include most of the mammalian mechanisms and also reveal novel (but potentially phylogenetically older) previously undetected mechanisms. We have matched the sequenced genomes of 65 fish species from the Ensemble database with the cancer gene information from the COSMIC database. By calculating the number of gene copies across species using the Ensembl CAFE data (providing species trees for gene copy number counts), we used a less resource‐demanding method for homolog identification. Our analysis demonstrates a masked relationship between cancer‐related gene copy number variation (CNV) and maximum lifespan in fish species, suggesting that a higher number of copies of tumour suppressor genes lengthens and the number of copies of oncogenes shortens lifespan. Based on the positive correlation between the number of copies of tumour suppressors and oncogenes, we show which species have more tumour suppressors in relation to oncogenes. It could be suggested that these species have stronger genetic defences against oncogenic processes. Fish studies could be a largely unexplored treasure trove for understanding the evolution and ecology of cancer, providing novel insights into the study of cancer and tumour suppression, in addition to fish evolution, life‐history trade‐offs, and ecology.
Collapse
Affiliation(s)
- Ciara Baines
- Institute of Ecology and Earth Sciences University of Tartu Tartu Estonia
- Estonian Marine Institute University of Tartu Tallinn Estonia
| | - Richard Meitern
- Institute of Ecology and Earth Sciences University of Tartu Tartu Estonia
| | - Randel Kreitsberg
- Institute of Ecology and Earth Sciences University of Tartu Tartu Estonia
| | - Tuul Sepp
- Institute of Ecology and Earth Sciences University of Tartu Tartu Estonia
| |
Collapse
|
11
|
Nunney L. Cancer suppression and the evolution of multiple retrogene copies of TP53 in elephants: a re‐evaluation. Evol Appl 2022; 15:891-901. [PMID: 35603034 PMCID: PMC9108310 DOI: 10.1111/eva.13383] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Revised: 03/27/2022] [Accepted: 04/02/2022] [Indexed: 11/28/2022] Open
Abstract
Evolving to become bigger and/or longer lived should increase cancer susceptibility, but this predicted increase is not observed, a contradiction named Peto's paradox. A solution is that cancer suppression evolves to minimize cancer susceptibility, and the discovery of 19 retrogene (RTG) copies of the tumor suppressor gene TP53 in the African elephant (Loxodonta africana) is increasingly cited as a classic example of such adaptive suppression. However, classic examples need rigorous evaluation and an alternative hypothesis is that the RTGs spread by genetic drift. This study shows that before its duplication, the ancestral elephant RTG was already truncated from 390 amino acids to 157 by a frameshift mutation, and that 14 of the 19 copies are now truncated to ≤88 amino acids. There was no compelling evidence of either positive or negative selection acting on these 88 codons, and the pattern of RTG accumulation fits a neutral model with a duplication rate of ~10−6 per generation. It is concluded that there is no evidence supporting the hypothesis that the 19 elephant RTGs spread to fixation by selection; instead, the evidence indicates that these RTGs accumulated primarily by segmental duplication and drift. It is shown that the evolutionary multistage model of carcinogenesis (EMMC) predicts the recruitment of 1–2 independently acting tumor suppressor genes to suppress the increased cancer risk in elephants, so it is possible that one or a few RTGs may have been favored by selection resulting in the known enhanced sensitivity of elephant cells to DNA damage. However, the analysis does not provide any support for either a direct (via conserved TP53 activity) or indirect (via supporting canonical TP53 function) role of the RTGs sequences, so that the presence of multiple copies of TP53 retrogenes in elephants needs to be further justified before being used as a classic example of tumor suppression in large‐bodied animals.
Collapse
Affiliation(s)
- Leonard Nunney
- Department of Evolution, Ecology, and Organismal Biology University of California Riverside 900 University Avenue Riverside CA 92521 USA
| |
Collapse
|
12
|
Demeter M, Derényi I, Szöllősi GJ. Trade-off between reducing mutational accumulation and increasing commitment to differentiation determines tissue organization. Nat Commun 2022; 13:1666. [PMID: 35351889 PMCID: PMC8964737 DOI: 10.1038/s41467-022-29004-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Accepted: 02/23/2022] [Indexed: 11/09/2022] Open
Abstract
Species-specific differences control cancer risk across orders of magnitude variation in body size and lifespan, e.g., by varying the copy numbers of tumor suppressor genes. It is unclear, however, how different tissues within an organism can control somatic evolution despite being subject to markedly different constraints, but sharing the same genome. Hierarchical differentiation, characteristic of self-renewing tissues, can restrain somatic evolution both by limiting divisional load, thereby reducing mutation accumulation, and by increasing cells’ commitment to differentiation, which can “wash out” mutants. Here, we explore the organization of hierarchical tissues that have evolved to limit their lifetime incidence of cancer. Estimating the likelihood of cancer in the presence of mutations that enhance self-proliferation, we demonstrate that a trade-off exists between mutation accumulation and the strength of washing out. Our results explain differences in the organization of widely different hierarchical tissues, such as colon and blood. The observation that tissues that undergo more stem cell divisions are less prone to develop cancer presents a paradox as these tissues should have more opportunity to accumulate cancer-causing mutations. Here, the authors present a solution to the paradox by showing how hierarchical tissues can maintain low cancer incidence by balancing mutation accumulation and the cells’ commitment to differentiation.
Collapse
|
13
|
Vincze O, Colchero F, Lemaître JF, Conde DA, Pavard S, Bieuville M, Urrutia AO, Ujvari B, Boddy AM, Maley CC, Thomas F, Giraudeau M. Cancer risk across mammals. Nature 2022; 601:263-267. [PMID: 34937938 PMCID: PMC8755536 DOI: 10.1038/s41586-021-04224-5] [Citation(s) in RCA: 71] [Impact Index Per Article: 35.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 11/09/2021] [Indexed: 12/13/2022]
Abstract
Cancer is a ubiquitous disease of metazoans, predicted to disproportionately affect larger, long-lived organisms owing to their greater number of cell divisions, and thus increased probability of somatic mutations1,2. While elevated cancer risk with larger body size and/or longevity has been documented within species3-5, Peto's paradox indicates the apparent lack of such an association among taxa6. Yet, unequivocal empirical evidence for Peto's paradox is lacking, stemming from the difficulty of estimating cancer risk in non-model species. Here we build and analyse a database on cancer-related mortality using data on adult zoo mammals (110,148 individuals, 191 species) and map age-controlled cancer mortality to the mammalian tree of life. We demonstrate the universality and high frequency of oncogenic phenomena in mammals and reveal substantial differences in cancer mortality across major mammalian orders. We show that the phylogenetic distribution of cancer mortality is associated with diet, with carnivorous mammals (especially mammal-consuming ones) facing the highest cancer-related mortality. Moreover, we provide unequivocal evidence for the body size and longevity components of Peto's paradox by showing that cancer mortality risk is largely independent of both body mass and adult life expectancy across species. These results highlight the key role of life-history evolution in shaping cancer resistance and provide major advancements in the quest for natural anticancer defences.
Collapse
Affiliation(s)
- Orsolya Vincze
- CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.
- Littoral, Environnement et Sociétés (LIENSs), UMR 7266 CNRS-La Rochelle Université, La Rochelle, France.
- Institute of Aquatic Ecology, Centre for Ecological Research, Debrecen, Hungary.
- Evolutionary Ecology Group, Hungarian Department of Biology and Ecology, Babeş-Bolyai University, Cluj-Napoca, Romania.
| | - Fernando Colchero
- Department of Mathematics and Computer Science, University of Southern Denmark, Odense, Denmark
- Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark
- Species360 Conservation Science Alliance, Bloomington, MN, USA
| | - Jean-Francois Lemaître
- Laboratoire de Biométrie et Biologie Evolutive, Université de Lyon, Université Lyon 1; CNRS,UMR5558, Villeurbanne, France
| | - Dalia A Conde
- Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark
- Species360 Conservation Science Alliance, Bloomington, MN, USA
- Department of Biology, University of Southern Denmark, Odense, Denmark
| | - Samuel Pavard
- Eco-Anthropologie (EA), Muséum National d'Histoire Naturelle, CNRS, Université de Paris, Musée de l'Homme, Paris, France
| | - Margaux Bieuville
- Eco-Anthropologie (EA), Muséum National d'Histoire Naturelle, CNRS, Université de Paris, Musée de l'Homme, Paris, France
| | - Araxi O Urrutia
- Instituto de Ecologia, UNAM, Mexico City, Mexico
- Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath, UK
| | - Beata Ujvari
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Geelong, Victoria, Australia
| | - Amy M Boddy
- Department of Anthropology, University of California Santa Barbara, Santa Barbara, CA, USA
| | - Carlo C Maley
- Arizona Cancer Evolution Center, Biodesign Institute and School of Life Sciences, Arizona State University, Tempe, AZ, USA
| | - Frédéric Thomas
- CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France
| | - Mathieu Giraudeau
- CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France
- Littoral, Environnement et Sociétés (LIENSs), UMR 7266 CNRS-La Rochelle Université, La Rochelle, France
| |
Collapse
|
14
|
Wu L, Zuo N, Pan S, Wang Y, Wang Q, Ma J. miR-1246 promotes laryngeal squamous cell carcinoma progression by interacting with THBS1. J Environ Pathol Toxicol Oncol 2022; 41:65-75. [DOI: 10.1615/jenvironpatholtoxicoloncol.2022040516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
15
|
Fortunato A, Fleming A, Aktipis A, Maley CC. Upregulation of DNA repair genes and cell extrusion underpin the remarkable radiation resistance of Trichoplax adhaerens. PLoS Biol 2021; 19:e3001471. [PMID: 34788294 PMCID: PMC8635375 DOI: 10.1371/journal.pbio.3001471] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 12/01/2021] [Accepted: 11/05/2021] [Indexed: 12/14/2022] Open
Abstract
Trichoplax adhaerens is the simplest multicellular animal with tissue differentiation and somatic cell turnover. Like all other multicellular organisms, it should be vulnerable to cancer, yet there have been no reports of cancer in T. adhaerens or any other placozoan. We investigated the cancer resistance of T. adhaerens, discovering that they are able to tolerate high levels of radiation damage (218.6 Gy). To investigate how T. adhaerens survive levels of radiation that are lethal to other animals, we examined gene expression after the X-ray exposure, finding overexpression of genes involved in DNA repair and apoptosis including the MDM2 gene. We also discovered that T. adhaerens extrudes clusters of inviable cells after X-ray exposure. T. adhaerens is a valuable model organism for studying the molecular, genetic, and tissue-level mechanisms underlying cancer suppression. The placozoan Trichoplax adhaerens is able to tolerate high levels of radiation and is resilient to DNA damage; this study reveals that exposure to X-rays triggers the extrusion of cell clusters which subsequently die, and that radiation exposure induces the overexpression of genes involved in DNA repair.
Collapse
Affiliation(s)
- Angelo Fortunato
- Arizona Cancer Evolution Center, Arizona State University, Tempe, Arizona, United States of America.,Biodesign Center for Biocomputing, Security and Society, Arizona State University, Arizona, United States of America.,School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| | - Alexis Fleming
- Arizona Cancer Evolution Center, Arizona State University, Tempe, Arizona, United States of America.,Biodesign Center for Biocomputing, Security and Society, Arizona State University, Arizona, United States of America
| | - Athena Aktipis
- Arizona Cancer Evolution Center, Arizona State University, Tempe, Arizona, United States of America.,Department of Psychology, Arizona State University, Tempe, Arizona, United States of America
| | - Carlo C Maley
- Arizona Cancer Evolution Center, Arizona State University, Tempe, Arizona, United States of America.,Biodesign Center for Biocomputing, Security and Society, Arizona State University, Arizona, United States of America.,School of Life Sciences, Arizona State University, Tempe, Arizona, United States of America
| |
Collapse
|
16
|
Abstract
Analogies between placentation, in particular the behavior of trophoblast cells, and cancer have been noted since the beginning of the twentieth century. To what degree these can be explained as a consequence of the evolution of placentation has been unclear. In this review, we conclude that many similarities between trophoblast and cancer cells are shared with other, phylogenetically older processes than placentation. The best candidates for cancer hallmarks that can be explained by the evolution of eutherian placenta are mechanisms of immune evasion. Another dimension of the maternal accommodation of the placenta with an impact on cancer malignancy is the evolution of endometrial invasibility. Species with lower degrees of placental invasion tend to have lower vulnerability to cancer malignancy. We finally identify several areas in which one could expect to see coevolutionary changes in placental and cancer biology but that, to our knowledge, have not been explored. Expected final online publication date for the Annual Review of Animal Biosciences, Volume 10 is February 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
Collapse
Affiliation(s)
- Günter P Wagner
- Systems Biology Institute, Yale University, West Haven, Connecticut, USA; , , .,Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA.,Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, Connecticut, USA.,Department of Obstetrics and Gynecology, Wayne State University, Detroit, Michigan, USA
| | - Kshitiz
- Department of Biomedical Engineering, University of Connecticut Health, Storrs, Connecticut, USA;
| | - Anasuya Dighe
- Systems Biology Institute, Yale University, West Haven, Connecticut, USA; , , .,Department of Ecology and Evolutionary Biology, Yale University, New Haven, Connecticut, USA
| | - Andre Levchenko
- Systems Biology Institute, Yale University, West Haven, Connecticut, USA; , , .,Department of Biomedical Engineering, Yale University, New Haven, Connecticut, USA
| |
Collapse
|
17
|
Omotoso O, Gladyshev VN, Zhou X. Lifespan Extension in Long-Lived Vertebrates Rooted in Ecological Adaptation. Front Cell Dev Biol 2021; 9:704966. [PMID: 34733838 PMCID: PMC8558438 DOI: 10.3389/fcell.2021.704966] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Accepted: 09/02/2021] [Indexed: 01/21/2023] Open
Abstract
Contemporary studies on aging and longevity have largely overlooked the role that adaptation plays in lifespan variation across species. Emerging evidence indicates that the genetic signals of extended lifespan may be maintained by natural selection, suggesting that longevity could be a product of organismal adaptation. The mechanisms of adaptation in long-lived animals are believed to account for the modification of physiological function. Here, we first review recent progress in comparative biology of long-lived animals, together with the emergence of adaptive genetic factors that control longevity and disease resistance. We then propose that hitchhiking of adaptive genetic changes is the basis for lifespan changes and suggest ways to test this evolutionary model. As individual adaptive or adaptation-linked mutations/substitutions generate specific forms of longevity effects, the cumulative beneficial effect is largely nonrandom and is indirectly favored by natural selection. We consider this concept in light of other proposed theories of aging and integrate these disparate ideas into an adaptive evolutionary model, highlighting strategies in decoding genetic factors of lifespan control.
Collapse
Affiliation(s)
- Olatunde Omotoso
- CAS Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Beijing, China.,University of Chinese Academy of Sciences, Beijing, China
| | - Vadim N Gladyshev
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States
| | - Xuming Zhou
- CAS Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Beijing, China
| |
Collapse
|
18
|
M. Dujon A, Brown JS, Destoumieux‐Garzón D, Vittecoq M, Hamede R, Tasiemski A, Boutry J, Tissot S, Alix‐Panabieres C, Pujol P, Renaud F, Simard F, Roche B, Ujvari B, Thomas F. On the need for integrating cancer into the One Health perspective. Evol Appl 2021; 14:2571-2575. [PMID: 34815739 PMCID: PMC8591323 DOI: 10.1111/eva.13303] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2021] [Revised: 09/10/2021] [Accepted: 09/12/2021] [Indexed: 12/11/2022] Open
Abstract
Recent pandemics have highlighted the urgency to connect disciplines studying animal, human, and environment health, that is, the "One Health" concept. The One Health approach takes a holistic view of health, but it has largely focused on zoonotic diseases while not addressing oncogenic processes. We argue that cancers should be an additional key focus in the One Health approach based on three factors that add to the well-documented impact of humans on the natural environment and its implications on cancer emergence. First, human activities are oncogenic to other animals, exacerbating the dynamics of oncogenesis, causing immunosuppressive disorders in wildlife with effects on host-pathogen interactions, and eventually facilitating pathogen spillovers. Second, the emergence of transmissible cancers in animal species (including humans) has the potential to accelerate biodiversity loss across ecosystems and to become pandemic. It is crucial to understand why, how, and when transmissible cancers emerge and spread. Third, translating knowledge of tumor suppressor mechanisms found across the Animal Kingdom to human health offers novel insights into cancer prevention and treatment strategies.
Collapse
Affiliation(s)
- Antoine M. Dujon
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
- School of Life and Environmental SciencesCentre for Integrative EcologyDeakin UniversityWaurn PondsVic.Australia
| | - Joel S. Brown
- Department of Integrated Mathematical OncologyMoffitt Cancer CenterTampaFloridaUSA
| | | | - Marion Vittecoq
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
- Tour du ValatResearch Institute for the Conservation of Mediterranean WetlandsArlesFrance
| | - Rodrigo Hamede
- School of Natural SciencesUniversity of TasmaniaHobartTas.Australia
| | - Aurélie Tasiemski
- Univ. LilleCNRSInsermCHU LilleInstitut Pasteur de LilleU1019‐UMR9017‐CIIL‐Centre d'Infection et d'Immunité de LilleLilleFrance
| | - Justine Boutry
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| | - Sophie Tissot
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| | - Catherine Alix‐Panabieres
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
- Laboratory of Rare Human Circulating Cells (LCCRH)University Medical Centre of MontpellierMontpellierFrance
| | - Pascal Pujol
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
- Oncogenetic DepartmentUniversity Medical Centre of MontpellierMontpellierFrance
| | - François Renaud
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| | - Frédéric Simard
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| | - Benjamin Roche
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| | - Beata Ujvari
- School of Life and Environmental SciencesCentre for Integrative EcologyDeakin UniversityWaurn PondsVic.Australia
| | - Frédéric Thomas
- CREEC/CANECEV (CREES)MontpellierFrance
- MIVEGECUniversité de Montpellier, CNRS, IRDMontpellierFrance
| |
Collapse
|
19
|
The One Medicine concept: its emergence from history as a systematic approach to re-integrate human and veterinary medicine. Emerg Top Life Sci 2021; 5:643-654. [PMID: 34355760 PMCID: PMC8718270 DOI: 10.1042/etls20200353] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2021] [Revised: 07/16/2021] [Accepted: 07/19/2021] [Indexed: 12/16/2022]
Abstract
The COVID-19 pandemic has resulted in the global recognition for greater inter-disciplinary and multi-disciplinary working, and the need for systematic approaches which recognise the interconnectedness and interactions between human, animal and environmental health. The notion of such a One Team/One science approach is perhaps best exemplified by the One Health concept, a systematic approach which is rapidly entering into the mainstream. However, the concept of One Health, as we presently know it, originated from One Medicine, a notion which is much older and which emerged to promote collaboration between the human and veterinary medicine professions and the allied health/scientific disciplines. Whilst One Medicine is perhaps better known by the veterinary community, some misconceptions of what One Medicine is have arisen. Therefore, this review introduces this emerging concept and how it can help to address overlapping (communicable and non-communicable disease) health challenges faced by both human and veterinary medicine.
Collapse
|
20
|
Tejada-Martinez D, de Magalhães JP, Opazo JC. Positive selection and gene duplications in tumour suppressor genes reveal clues about how cetaceans resist cancer. Proc Biol Sci 2021; 288:20202592. [PMID: 33622125 DOI: 10.1098/rspb.2020.2592] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Cetaceans are the longest-living species of mammals and the largest in the history of the planet. They have developed mechanisms against diseases such cancer, although the underlying molecular bases of these remain unknown. The goal of this study was to investigate the role of natural selection in the evolution of 1077 tumour suppressor genes (TSGs) in cetaceans. We used a comparative genomic approach to analyse two sources of molecular variation in the form of dN/dS rates and gene copy number variation. We found a signal of positive selection in the ancestor of cetaceans within the CXCR2 gene, an important regulator of DNA damage, tumour dissemination and immune system. Further, in the ancestor of baleen whales, we found six genes exhibiting positive selection relating to diseases such as breast carcinoma, lung neoplasm (ADAMTS8) and leukaemia (ANXA1). The TSGs turnover rate (gene gain and loss) was almost 2.4-fold higher in cetaceans when compared with other mammals, and notably even faster in baleen whales. The molecular variants in TSGs found in baleen whales, combined with the faster gene turnover rate, could have favoured the evolution of their particular traits of anti-cancer resistance, gigantism and longevity. Additionally, we report 71 genes with duplications, of which 11 genes are linked to longevity (e.g. NOTCH3 and SIK1) and are important regulators of senescence, cell proliferation and metabolism. Overall, these results provide evolutionary evidence that natural selection in TSGs could act on species with large body sizes and extended lifespan, providing novel insights into the genetic basis of disease resistance.
Collapse
Affiliation(s)
- Daniela Tejada-Martinez
- Programa de Doctorado en Ciencias mención Ecología y Evolución, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.,Instituto de Ciencias Ambientales y Evolutivas, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.,Integrative Genomics of Ageing Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool L7 8TX, UK.,Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA
| | - João Pedro de Magalhães
- Integrative Genomics of Ageing Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool L7 8TX, UK
| | - Juan C Opazo
- Instituto de Ciencias Ambientales y Evolutivas, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile.,Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Valdivia, Chile.,Integrative Biology Group, Universidad Austral de Chile, Valdivia, Chile
| |
Collapse
|
21
|
Nunney L, Thai K. Determining cancer risk: the evolutionary multistage model or total stem cell divisions? Proc Biol Sci 2020; 287:20202291. [PMID: 33323077 DOI: 10.1098/rspb.2020.2291] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022] Open
Abstract
A recent hypothesis proposed that the total number of stem cell divisions in a tissue (TSCD model) determine its intrinsic cancer risk; however, a different model-the multistage model-has long been used to understand how cancer originates. Identifying the correct model has important implications for interpreting the frequency of cancers. Using worldwide cancer incidence data, we applied three tests to the TSCD model and an evolutionary multistage model of carcinogenesis (EMMC), a model in which cancer suppression is recognized as an evolving trait, with natural selection acting to suppress cancers causing a significant mean loss of Darwinian fitness. Each test supported the EMMC but contradicted the TSCD model. This outcome undermines results based on the TSCD model quantifying the relative importance of 'bad luck' (the random accumulation of somatic mutations) versus environmental and genetic factors in determining cancer incidence. Our testing supported the EMMC prediction that cancers of large rapidly dividing tissues predominate late in life. Another important prediction is that an indicator of recent oncogenic environmental change is an unusually high mean fitness loss due to cancer, rather than a high lifetime incidence. The evolutionary model also predicts that large and/or long-lived animals have evolved mechanisms of cancer suppression that may be of value in preventing or controlling human cancers.
Collapse
Affiliation(s)
- Leonard Nunney
- Department of Evolution, Ecology and Organismal Biology, University of California, Riverside, CA 92521, USA
| | - Kevin Thai
- Department of Evolution, Ecology and Organismal Biology, University of California, Riverside, CA 92521, USA
| |
Collapse
|
22
|
Boutry J, Dujon AM, Gerard AL, Tissot S, Macdonald N, Schultz A, Biro PA, Beckmann C, Hamede R, Hamilton DG, Giraudeau M, Ujvari B, Thomas F. Ecological and Evolutionary Consequences of Anticancer Adaptations. iScience 2020; 23:101716. [PMID: 33241195 PMCID: PMC7674277 DOI: 10.1016/j.isci.2020.101716] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Cellular cheating leading to cancers exists in all branches of multicellular life, favoring the evolution of adaptations to avoid or suppress malignant progression, and/or to alleviate its fitness consequences. Ecologists have until recently largely neglected the importance of cancer cells for animal ecology, presumably because they did not consider either the potential ecological or evolutionary consequences of anticancer adaptations. Here, we review the diverse ways in which the evolution of anticancer adaptations has significantly constrained several aspects of the evolutionary ecology of multicellular organisms at the cell, individual, population, species, and ecosystem levels and suggest some avenues for future research.
Collapse
Affiliation(s)
- Justine Boutry
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
| | - Antoine M. Dujon
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
| | - Anne-Lise Gerard
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
| | - Sophie Tissot
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
| | - Nick Macdonald
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
| | - Aaron Schultz
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
| | - Peter A. Biro
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
| | - Christa Beckmann
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
- School of Science, Western Sydney University, Parramatta, NSW, Australia
- Hawkesbury Institute for the Environment, Western Sydney University, Penrith, NSW, Australia
| | - Rodrigo Hamede
- School of Natural Sciences, University of Tasmania, Hobart, TAS, Australia
| | - David G. Hamilton
- School of Natural Sciences, University of Tasmania, Hobart, TAS, Australia
| | - Mathieu Giraudeau
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
| | - Beata Ujvari
- Centre for Integrative Ecology, School of Life and Environmental Sciences, Deakin University, Waurn Ponds, VIC, Australia France
- School of Natural Sciences, University of Tasmania, Hobart, TAS, Australia
| | - Frédéric Thomas
- CREEC/CANECEV (CREES), MIVEGEC, Unité Mixte de Recherches, IRD 224–CNRS 5290–Université de Montpellier, Montpellier, France
| |
Collapse
|
23
|
Abstract
Dr Francesca Ciccarelli (The Francis Crick Institute, UK) and Dr James De Gregori (University of Colorado, USA) interview 3 top scientists in clinical (Dr Charles Swanton, The Francis Crick Institute, UK), molecular (Dr Kornelia Polyak, Dana-Farber Cancer Institute, USA), and evolutionary cancer research (Dr Carlo Maley, Arizona State University, USA) to discuss the current status of knowledge, the challenges, and the opportunities to move the field forward.
Collapse
Affiliation(s)
- Francesca D. Ciccarelli
- Cancer Systems Biology Laboratory, the Francis Crick Institute, London, NW1 1AT, UK
- School of Cancer and Pharmaceutical Sciences, King's College London, London SE11UL, UK
| | - James DeGregori
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, U S A
| |
Collapse
|
24
|
Nunney L. Resolving Peto's paradox: Modeling the potential effects of size-related metabolic changes, and of the evolution of immune policing and cancer suppression. Evol Appl 2020; 13:1581-1592. [PMID: 32821274 PMCID: PMC7428811 DOI: 10.1111/eva.12993] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Revised: 04/29/2020] [Accepted: 04/30/2020] [Indexed: 12/20/2022] Open
Abstract
The intrinsic risk of cancer increases with body size and longevity; however, big long-lived species do not exhibit this increase, a contradiction named Peto's paradox. Five hypotheses potentially resolving this paradox were modeled using the multistage model of carcinogenesis. The five hypotheses were based on (1) intrinsic changes in metabolic rate with body size; adaptive increase in immune policing of (2) cancer cells or (3) cells with driver mutations; or adaptive increase in cancer suppression via (4) decreased somatic mutation rate, or (5) increased genetic control. Parameter changes needed to stabilize cancer risk in three types of cancer were estimated for tissues scaled from mouse size and longevity to human and blue whale levels. The metabolic rate hypothesis alone was rejected due to a conflict between the required interspecific effect with the observed intraspecific effect of size on cancer risk, but some metabolic change was optionally incorporated in the other models. Necessary parameter changes in immune policing and somatic mutation rate far exceeded values observed; however, natural selection increasing the genetic suppression of cancer was generally consistent with data. Such adaptive increases in genetic control of cancers in large and/or long-lived animals raise the possibility that nonmodel animals will reveal novel anticancer mechanisms.
Collapse
Affiliation(s)
- Leonard Nunney
- Department of Evolution, Ecology, and Organismal BiologyUniversity of California RiversideRiversideCAUSA
| |
Collapse
|
25
|
Gatenby RA, Avdieiev S, Tsai KY, Brown JS. Integrating genetic and nongenetic drivers of somatic evolution during carcinogenesis: The biplane model. Evol Appl 2020; 13:1651-1659. [PMID: 32952610 PMCID: PMC7484850 DOI: 10.1111/eva.12973] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2019] [Revised: 03/26/2020] [Accepted: 03/30/2020] [Indexed: 12/12/2022] Open
Abstract
The multistep transition from a normal to a malignant cellular phenotype is often termed "somatic evolution" caused by accumulating random mutations. Here, we propose an alternative model in which the initial genetic state of a cancer cell is the result of mutations that occurred throughout the lifetime of the host. However, these mutations are not carcinogenic because normal cells in multicellular organism cannot ordinarily evolve. That is, proliferation and death of normal cells are controlled by local tissue constraints typically governed by nongenomic information dynamics in the cell membrane. As a result, the cells of a multicellular organism have a fitness that is identical to the host, which is then the unit of natural selection. Somatic evolution of a cell can occur only when its fate becomes independent of host constraints. Now, survival, proliferation, and death of individual cells are dependent on Darwinian dynamics. This cellular transition from host-defined fitness to self-defined fitness may, consistent with the conventional view of carcinogenesis, result from mutations that render the cell insensitive to host controls. However, an identical state will result when surrounding tissue cannot exert control because of injury, inflammation, aging, or infection. Here, all surviving cells within the site of tissue damage default to self-defined fitness functions allowing them to evolve so that the mutations accumulated over the lifetime of the host now serve as the genetic heritage of an evolutionary unit of selection. Furthermore, tissue injury generates a new ecology cytokines and growth factors that might promote proliferation in cells with prior receptor mutations. This model integrates genetic and nongenetic dynamics into cancer development and is consistent with both clinical observations and prior experiments that divided carcinogenesis to initiation, promotion, and progression steps.
Collapse
Affiliation(s)
| | | | - Kenneth Y. Tsai
- Cancer Biology and Evolution ProgramMoffitt Cancer CenterTampaFLUSA
| | - Joel S. Brown
- Cancer Biology and Evolution ProgramMoffitt Cancer CenterTampaFLUSA
| |
Collapse
|
26
|
Kitsoulis CV, Baxevanis AD, Abatzopoulos TJ. The occurrence of cancer in vertebrates: a mini review. ACTA ACUST UNITED AC 2020; 27:9. [PMID: 32528906 PMCID: PMC7282124 DOI: 10.1186/s40709-020-00119-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 06/01/2020] [Indexed: 12/26/2022]
Abstract
Neoplasia is a multilevel condition caused by irregularities over the genome, which can lead to a fatal result. To fully understand this phenomenon, an evolutionary challenge has risen during the last decades, away from human limits, driving the scientific quest into the wild life. The study of wild vertebrate populations in their natural habitats has shown that cancer is rather prominent. Thus, the diversity of vertebrates reported with some form of neoplasia is quite scattered through a variety of habitats. However, some species constitute exceptions by exhibiting cancer-protective features, driven by certain loci in their DNA. It is obvious that from an evolutionary standpoint, the incidence of cancer in different taxa is nowadays studied by seeking for patterns and their roots. The main purpose of the evolutionary approach is no other than to answer a fundamental question: Could cancer be ultimately regarded as another evolutionary force conducive to the formation or shaping-up of species?
Collapse
Affiliation(s)
- Christos V Kitsoulis
- Department of Genetics, Development & Molecular Biology, School of Biology, Faculty of Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| | - Athanasios D Baxevanis
- Department of Genetics, Development & Molecular Biology, School of Biology, Faculty of Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| | - Theodore J Abatzopoulos
- Department of Genetics, Development & Molecular Biology, School of Biology, Faculty of Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| |
Collapse
|
27
|
Lustgarten JL, Zehnder A, Shipman W, Gancher E, Webb TL. Veterinary informatics: forging the future between veterinary medicine, human medicine, and One Health initiatives-a joint paper by the Association for Veterinary Informatics (AVI) and the CTSA One Health Alliance (COHA). JAMIA Open 2020; 3:306-317. [PMID: 32734172 PMCID: PMC7382640 DOI: 10.1093/jamiaopen/ooaa005] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 12/26/2019] [Accepted: 02/26/2020] [Indexed: 12/25/2022] Open
Abstract
Objectives This manuscript reviews the current state of veterinary medical electronic health records and the ability to aggregate and analyze large datasets from multiple organizations and clinics. We also review analytical techniques as well as research efforts into veterinary informatics with a focus on applications relevant to human and animal medicine. Our goal is to provide references and context for these resources so that researchers can identify resources of interest and translational opportunities to advance the field. Methods and Results This review covers various methods of veterinary informatics including natural language processing and machine learning techniques in brief and various ongoing and future projects. After detailing techniques and sources of data, we describe some of the challenges and opportunities within veterinary informatics as well as providing reviews of common One Health techniques and specific applications that affect both humans and animals. Discussion Current limitations in the field of veterinary informatics include limited sources of training data for developing machine learning and artificial intelligence algorithms, siloed data between academic institutions, corporate institutions, and many small private practices, and inconsistent data formats that make many integration problems difficult. Despite those limitations, there have been significant advancements in the field in the last few years and continued development of a few, key, large data resources that are available for interested clinicians and researchers. These real-world use cases and applications show current and significant future potential as veterinary informatics grows in importance. Veterinary informatics can forge new possibilities within veterinary medicine and between veterinary medicine, human medicine, and One Health initiatives.
Collapse
Affiliation(s)
- Jonathan L Lustgarten
- Association for Veterinary Informatics, Dixon, California, USA.,VCA Inc., Health Technology & Informatics, Los Angeles, California, USA
| | | | - Wayde Shipman
- Veterinary Medical Databases, Columbia, Missouri, USA
| | - Elizabeth Gancher
- Department of Infectious diseases and HIV medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA
| | - Tracy L Webb
- Department of Clinical Sciences, Colorado State University, Fort Collins, Colorado, USA
| |
Collapse
|
28
|
Davey Smith G. Post-Modern Epidemiology: When Methods Meet Matter. Am J Epidemiol 2019; 188:1410-1419. [PMID: 30877306 PMCID: PMC6670067 DOI: 10.1093/aje/kwz064] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 02/26/2019] [Accepted: 02/26/2019] [Indexed: 12/17/2022] Open
Abstract
In the last third of the 20th century, etiological epidemiology within academia in high-income countries shifted its primary concern from attempting to tackle the apparent epidemic of noncommunicable diseases to an increasing focus on developing statistical and causal inference methodologies. This move was mutually constitutive with the failure of applied epidemiology to make major progress, with many of the advances in understanding the causes of noncommunicable diseases coming from outside the discipline, while ironically revealing the infectious origins of several major conditions. Conversely, there were many examples of epidemiologic studies promoting ineffective interventions and little evident attempt to account for such failure. Major advances in concrete understanding of disease etiology have been driven by a willingness to learn about and incorporate into epidemiology developments in biology and cognate data science disciplines. If fundamental epidemiologic principles regarding the rooting of disease risk within populations are retained, recent methodological developments combined with increased biological understanding and data sciences capability should herald a fruitful post-Modern Epidemiology world.
Collapse
Affiliation(s)
- George Davey Smith
- Medical Research Council Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom
| |
Collapse
|
29
|
Brouwer AF, Eisenberg MC, Meza R. Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence. Cancer Res 2019; 78:3386-3396. [PMID: 29907681 DOI: 10.1158/0008-5472.can-17-3467] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Revised: 03/09/2018] [Accepted: 04/13/2018] [Indexed: 12/26/2022]
Abstract
Obtaining detailed individual-level data on both exposure and cancer outcomes is challenging, and it is difficult to understand and characterize how temporal aspects of exposures translate into cancer risk. We show that, in lieu of individual-level information, population-level data on cancer incidence and etiologic agent prevalence can be leveraged to investigate cancer mechanisms and to better characterize and predict cancer trends. We use mechanistic carcinogenesis models [multistage clonal expansion (MSCE) models] and data on smoking, Helicobacter pylori (H. pylori), and HPV infection prevalence to investigate trends of lung, gastric, and HPV-related oropharyngeal cancers. MSCE models are based on the initiation-promotion-malignant conversion paradigm and allow for interpretation of trends in terms of general biological mechanisms. We assumed the rates of initiation depend on the prevalence of the corresponding risk factors. We performed two types of analysis, using the agent prevalence and cancer incidence data to estimate the model parameters and using cancer incidence data to infer the etiologic agent prevalence as well as the model parameters. By including risk factor prevalence, MSCE models with as few as three parameters closely reproduced 40 years of age-specific cancer incidence data. We recovered trends of H. pylori prevalence in the United States and demonstrated that cohort effects can explain the observed bimodal, age-specific pattern of oral HPV prevalence in men. Our results demonstrate the potential for joint analyses of population-level cancer and risk factor data through mechanistic modeling. This approach can be a first step in systematically testing relationships between exposures and cancer risk when individual-level data is lacking.Significance: Analysis of trends in risk-factor prevalence and cancer incidence can shed light on cancer mechanisms and the way that carcinogen exposure through time shapes the risk of cancer at different ages.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/12/3386/F1.large.jpg Cancer Res; 78(12); 3386-96. ©2018 AACR.
Collapse
Affiliation(s)
- Andrew F Brouwer
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan.
| | | | - Rafael Meza
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan
| |
Collapse
|
30
|
Lemaître J, Pavard S, Giraudeau M, Vincze O, Jennings G, Hamede R, Ujvari B, Thomas F. Eco‐evolutionary perspectives of the dynamic relationships linking senescence and cancer. Funct Ecol 2019. [DOI: 10.1111/1365-2435.13394] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Jean‐François Lemaître
- Université de Lyon, F‐69000, Lyon; Université Lyon 1; CNRS, UMR5558 Laboratoire de Biométrie et Biologie Évolutive F‐69622 Villeurbanne France
| | - Samuel Pavard
- Unité Eco-anthropologie (EA), Muséum National d’Histoire Naturelle, CNRS 7206 Université Paris Diderot Paris France
| | | | - Orsolya Vincze
- Hungarian Department of Biology and Ecology, Evolutionary Ecology Group Babeş‐Bolyai University Cluj‐Napoca Romania
- Department of Tisza Research MTA Centre for Ecological Research Debrecen Hungary
| | - Geordie Jennings
- Centre for Integrative Ecology, School of Life and Environmental Sciences Deakin University Waurn Ponds Victoria Australia
- School of Natural Sciences University of Tasmania Hobart Tasmania Australia
| | - Rodrigo Hamede
- Centre for Integrative Ecology, School of Life and Environmental Sciences Deakin University Waurn Ponds Victoria Australia
- School of Natural Sciences University of Tasmania Hobart Tasmania Australia
| | - Beata Ujvari
- Centre for Integrative Ecology, School of Life and Environmental Sciences Deakin University Waurn Ponds Victoria Australia
| | | |
Collapse
|
31
|
Passow CN, Bronikowski AM, Blackmon H, Parsai S, Schwartz TS, McGaugh SE. Contrasting Patterns of Rapid Molecular Evolution within the p53 Network across Mammal and Sauropsid Lineages. Genome Biol Evol 2019; 11:629-643. [PMID: 30668691 PMCID: PMC6406535 DOI: 10.1093/gbe/evy273] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/04/2019] [Indexed: 12/13/2022] Open
Abstract
Cancer is a threat to multicellular organisms, yet the molecular evolution of pathways that prevent the accumulation of genetic damage has been largely unexplored. The p53 network regulates how cells respond to DNA-damaging stressors. We know little about p53 network molecular evolution as a whole. In this study, we performed comparative genetic analyses of the p53 network to quantify the number of genes within the network that are rapidly evolving and constrained, and the association between lifespan and the patterns of evolution. Based on our previous published data set, we used genomes and transcriptomes of 34 sauropsids and 32 mammals to analyze the molecular evolution of 45 genes within the p53 network. We found that genes in the network exhibited evidence of positive selection and divergent molecular evolution in mammals and sauropsids. Specifically, we found more evidence of positive selection in sauropsids than mammals, indicating that sauropsids have different targets of selection. In sauropsids, more genes upstream in the network exhibited positive selection, and this observation is driven by positive selection in squamates, which is consistent with previous work showing rapid divergence and adaptation of metabolic and stress pathways in this group. Finally, we identified a negative correlation between maximum lifespan and the number of genes with evidence of divergent molecular evolution, indicating that species with longer lifespans likely experienced less variation in selection across the network. In summary, our study offers evidence that comparative genomic approaches can provide insights into how molecular networks have evolved across diverse species.
Collapse
Affiliation(s)
- Courtney N Passow
- Department of Ecology, Evolution, and Behavior, University of Minnesota
| | - Anne M Bronikowski
- Department of Ecology, Evolution, and Organismal Biology, Iowa State University
| | - Heath Blackmon
- Department of Ecology, Evolution, and Behavior, University of Minnesota
- Department of Biology, Texas A&M University, College Station, TX
| | - Shikha Parsai
- Department of Ecology, Evolution, and Organismal Biology, Iowa State University
| | - Tonia S Schwartz
- Department of Ecology, Evolution, and Organismal Biology, Iowa State University
- Department of Biological Sciences, Auburn University, Auburn, AL
| | - Suzanne E McGaugh
- Department of Ecology, Evolution, and Behavior, University of Minnesota
| |
Collapse
|
32
|
Risques RA, Promislow DEL. All's well that ends well: why large species have short telomeres. Philos Trans R Soc Lond B Biol Sci 2019; 373:rstb.2016.0448. [PMID: 29335372 DOI: 10.1098/rstb.2016.0448] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/29/2017] [Indexed: 12/11/2022] Open
Abstract
Among mammal species, almost all life-history traits are strongly size dependent. This size dependence even occurs at a molecular level. For example, both telomere length and telomerase expression show a size-dependent threshold. With some exceptions, species smaller than approximately 2 kg express telomerase, while species larger than that do not. Among species greater than approximately 5 kg, telomeres tend to be short-less than 25 kb-while among smaller species, some species have short and some have long telomeres. Here, we present a model to explore the role of body size-dependent trade-offs in shaping this threshold. We assume that selection favours short telomeres as a mechanism to protect against cancer. At the same time, selection favours long telomeres as a protective mechanism against DNA damage and replicative senescence. The relative importance of these two selective forces will depend on underlying intrinsic mortality and risk of cancer, both of which are size-dependent. Results from this model suggest that a cost-benefit model for the evolution of telomere length could explain phylogenetic patterns observed within the Class Mammalia. In addition, the model suggests a general conceptual framework to think about the role that body size plays in the evolution of tumour suppressor mechanisms.This article is part of the theme issue 'Understanding diversity in telomere dynamics'.
Collapse
Affiliation(s)
- Rosa Ana Risques
- Department of Pathology, University of Washington, Seattle, WA 98195, USA
| | - Daniel E L Promislow
- Department of Pathology, University of Washington, Seattle, WA 98195, USA.,Department of Biology, University of Washington, Seattle, WA 98195, USA
| |
Collapse
|
33
|
Lage A, Romero T. Back and forth between cancer treatment and cancer control programs: Insights from the Cuban experience. Semin Oncol 2018; 45:12-17. [PMID: 30318079 DOI: 10.1053/j.seminoncol.2018.04.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Accepted: 04/20/2018] [Indexed: 01/04/2023]
Abstract
Cancer control is a wider concept than oncology, and includes comprehensive actions for prevention, early diagnosis, treatment, services organization, and education, aiming to modify hard indicators such as incidence, mortality rates, and survival at a population scale. Based on these concepts, organized national cancer programs appeared in several countries in the second half of the 20th century. But at the same time, scientific efforts began to modify the landscape of cancer control. Evidence of mortality reductions began to appear, cancer-driving mutations became measurable, many novel drugs were registered, the methodology of clinical trials spread through health systems, targeted drugs and immunotherapy entered into the mainstream of therapeutics, and treatment goals started to shift from cure to chronic control. The implementation and impact of organized interventions for cancer control show variations according to the context of diverse countries, and scientists and health decision makers can learn from studying these diverse experiences. Among the salient features of cancer control in Cuba are the simultaneous development of a primary care network with abundant human resources and a national biotechnology industry with capacity to provide both generic and innovating drugs and diagnostic systems. The program intentionally assumes the goal of accelerating the transformation of advanced cancer into a chronic disease susceptible of long-term control. The implications of this strategy for population interventions and for scientific research are discussed.
Collapse
Affiliation(s)
| | - Teresa Romero
- Cancer Control Section, Cuban Ministry of Health, Havana, Cuba
| |
Collapse
|
34
|
Costanzo V, Bardelli A, Siena S, Abrignani S. Exploring the links between cancer and placenta development. Open Biol 2018; 8:180081. [PMID: 29950452 PMCID: PMC6030113 DOI: 10.1098/rsob.180081] [Citation(s) in RCA: 97] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2018] [Accepted: 06/05/2018] [Indexed: 12/19/2022] Open
Abstract
The development of metastatic cancer is a multistage process, which often requires decades to complete. Impairments in DNA damage control and DNA repair in cancer cell precursors generate genetically heterogeneous cell populations. However, despite heterogeneity most solid cancers have stereotypical behaviours, including invasiveness and suppression of immune responses that can be unleashed with immunotherapy targeting lymphocyte checkpoints. The mechanisms leading to the acquisition of stereotypical properties remain poorly understood. Reactivation of embryonic development processes in cells with unstable genomes might contribute to tumour expansion and metastasis formation. However, it is unclear whether these events are linked to immune response modulation. Tumours and embryos have non-self-components and need to avoid immune responses in their microenvironment. In mammalian embryos, neo-antigens are of paternal origin, while in tumour cells DNA mismatch repair and replication defects generate them. Inactivation of the maternal immune response towards the embryo, which occurs at the placental-maternal interface, is key to ensuring embryonic development. This regulation is accomplished by the trophoblast, which mimics several malignant cell features, including the ability to invade normal tissues and to avoid host immune responses, often adopting the same cancer immunoediting strategies. A better understanding as to whether and how genotoxic stress promotes cancer development through reactivation of programmes occurring during early stages of mammalian placentation could help to clarify resistance to drugs targeting immune checkpoint and DNA damage responses and to develop new therapeutic strategies to eradicate cancer.
Collapse
Affiliation(s)
- Vincenzo Costanzo
- IFOM, The FIRC Institute of Molecular Oncology, University of Milan Medical School, Milan, Italy
- Department of Oncology, University of Milan Medical School, Milan, Italy
| | - Alberto Bardelli
- Candiolo Cancer Institute-FPO, IRCCS, University of Turin, Candiolo, Turin, Italy
- Department of Oncology, University of Turin, Candiolo, Turin, Italy
| | - Salvatore Siena
- Department of Oncology, University of Milan Medical School, Milan, Italy
- Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - Sergio Abrignani
- INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy
- University of Milan Medical School, Milan, Italy
| |
Collapse
|
35
|
Vittecoq M, Giraudeau M, Sepp T, Marcogliese DJ, Klaassen M, Renaud F, Ujvari B, Thomas F. Turning natural adaptations to oncogenic factors into an ally in the war against cancer. Evol Appl 2018; 11:836-844. [PMID: 29928293 PMCID: PMC5999213 DOI: 10.1111/eva.12608] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Accepted: 01/25/2018] [Indexed: 12/14/2022] Open
Abstract
Both field and experimental evolution studies have demonstrated that organisms naturally or artificially exposed to environmental oncogenic factors can, sometimes rapidly, evolve specific adaptations to cope with pollutants and their adverse effects on fitness. Although numerous pollutants are mutagenic and carcinogenic, little attention has been given to exploring the extent to which adaptations displayed by organisms living in oncogenic environments could inspire novel cancer treatments, through mimicking the processes allowing these organisms to prevent or limit malignant progression. Building on a substantial knowledge base from the literature, we here present and discuss this progressive and promising research direction, advocating closer collaboration between the fields of medicine, ecology, and evolution in the war against cancer.
Collapse
Affiliation(s)
- Marion Vittecoq
- Institut de Recherche de la Tour du Valat Arles France.,CREEC/MIVEGEC IRD CNRS University of Montpellier Montpellier France
| | - Mathieu Giraudeau
- School of Life Sciences Arizona State University Tempe AZ USA.,Centre for Ecology & Conservation College of Life and Environmental Sciences University of Exeter Penryn UK
| | - Tuul Sepp
- School of Life Sciences Arizona State University Tempe AZ USA.,Department of Zoology University of Tartu Tartu Estonia
| | - David J Marcogliese
- Aquatic Contaminants Research Division Water Science and Technology Directorate Environment and Climate Change Canada St. Lawrence Centre Montreal QC Canada.,Fisheries and Oceans Canada St. Andrews Biological Station St. Andrews NB Canada
| | - Marcel Klaassen
- School of Life and Environmental Sciences Centre for Integrative Ecology Deakin University Deakin Vic. Australia
| | - François Renaud
- CREEC/MIVEGEC IRD CNRS University of Montpellier Montpellier France
| | - Beata Ujvari
- School of Life and Environmental Sciences Centre for Integrative Ecology Deakin University Deakin Vic. Australia.,School of Biological Sciences University of Tasmania Hobart TAS Australia
| | - Frédéric Thomas
- CREEC/MIVEGEC IRD CNRS University of Montpellier Montpellier France
| |
Collapse
|
36
|
Aviv A, Anderson JJ, Shay JW. Mutations, Cancer and the Telomere Length Paradox. Trends Cancer 2017; 3:253-258. [PMID: 28718437 PMCID: PMC5903276 DOI: 10.1016/j.trecan.2017.02.005] [Citation(s) in RCA: 88] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2016] [Revised: 02/22/2017] [Accepted: 02/23/2017] [Indexed: 12/30/2022]
Abstract
Individuals with short telomeres should be at increased risk for cancer, since short telomeres lead to genomic instability - a hallmark of cancer. However, individuals with long telomeres also display an increased risk for major cancers, thus creating a cancer-telomere length (TL) paradox. The two-stage clonal expansion model we propose is based on the thesis that a series of mutational hits (1st Hit) at the stem-cell level generates a clone with replicative advantage. A series of additional mutational hits (2nd Hit) transforms the expanding clone into cancer. By proposing that the 1st Hit is largely telomere length-independent, while the 2nd Hit is largely TL-dependent, we resolve the paradox, highlighting a regulatory role of telomeres in cancer.
Collapse
Affiliation(s)
- Abraham Aviv
- The Center of Human Development and Aging, New Jersey Medical School, Rutgers, Newark, NJ 07103, USA.
| | - James J Anderson
- Center for Statistics and the Social Sciences and Center for Studies in Demography and Ecology, University of Washington, Seattle, WA 98105, USA
| | - Jerry W Shay
- Department of Cell Biology, UT Southwestern Medical Center, Dallas TX, 75390, USA; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
| |
Collapse
|
37
|
Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2017; 2017:9830342. [PMID: 28270854 PMCID: PMC5320322 DOI: 10.1155/2017/9830342] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Accepted: 01/09/2017] [Indexed: 01/22/2023]
Abstract
Rhus verniciflua Stoke has been commonly used in traditional medicine to treat gastrointestinal (GI) dysfunction diseases. In order to investigate pharmacological properties of Rhus verniciflua Stoke water extract (RVX) on cisplatin-induced amnesia, RVX (0, 25, 50, or 100 mg/kg) was orally administrated for five consecutive days after a single intraperitoneal injection of cisplatin (6 mg/kg) to SD rat. Cisplatin injection significantly increased the kaolin intake (emesis) but reduced the normal diet intake (anorexia) whereas the RVX treatment significantly improved these abnormal diet behaviors at both the acute and delayed phase. The serotonin concentration and the related gene expressions (5-HT3 receptors and SERT) in small intestine tissue were abnormally altered by cisplatin injection, which were significantly attenuated by the RVX treatment. Histological findings of gastrointestinal tracts, as well as the proteins level of proinflammatory cytokines (TNF-α, IL-6, and IL-1β), revealed the beneficial effect of RVX on cisplatin-induced gastrointestinal inflammation. In addition, RVX significantly improved cisplatin-induced myelosuppression, as evidenced by the observation of leukopenia and by histological examinations in bone marrow. Our findings collectively indicated Rhus verniciflua Stoke improved the resistance of rats to chemotherapy-related adverse effects in the gastrointestinal track and bone marrow.
Collapse
|
38
|
Hochberg ME, Noble RJ. A framework for how environment contributes to cancer risk. Ecol Lett 2017; 20:117-134. [DOI: 10.1111/ele.12726] [Citation(s) in RCA: 49] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2016] [Revised: 10/03/2016] [Accepted: 12/01/2016] [Indexed: 12/22/2022]
Affiliation(s)
- Michael E. Hochberg
- Intstitut des Sciences de l'Evolution de Montpellier; Université de Montpellier; Place E. Bataillon, CC065 34095 Montpellier Cedex 5 France
- Santa Fe Institute; 1399 Hyde Park Rd. Santa Fe NM 87501 USA
| | - Robert J. Noble
- Intstitut des Sciences de l'Evolution de Montpellier; Université de Montpellier; Place E. Bataillon, CC065 34095 Montpellier Cedex 5 France
| |
Collapse
|
39
|
Abstract
There is significant recent interest in Peto's paradox and the related problem of the evolution of large, long-lived organisms in terms of cancer robustness. Peto's paradox refers to the expectation that large, long-lived organisms have a higher lifetime cancer risk, which is not the case: a paradox. This paradox, however, is circular: large, long-lived organisms are large and long-lived because they are cancer robust. Lifetime risk, meanwhile, depends on the age distributions of both cancer and competing risks: if cancer strikes before competing risks, then lifetime risk is high; if not, not. Because no set of competing risks is generally prevalent, it is instructive to temporarily dispose of competing risks and investigate the pure age dynamics of cancer under the multistage model of carcinogenesis. In addition to augmenting earlier results, I show that in terms of cancer-free lifespan large organisms reap greater benefits from an increase in cellular cancer robustness than smaller organisms. Conversely, a higher cellular cancer robustness renders cancer-free lifespan more resilient to an increase in size. This interaction may be an important driver of the evolution of large, cancer-robust organisms.
Collapse
Affiliation(s)
- Maarten J Wensink
- Max Planck Odense Center on the Biodemography of Aging, University of Southern Denmark, Winsløws Vej 9B, 5000 C Odense, Denmark Institute of Public Health, University of Southern Denmark, Winsløws Vej 9B, 5000 C Odense, Denmark
| |
Collapse
|
40
|
Takemoto K, Ii M, Nishizuka SS. Importance of metabolic rate to the relationship between the number of genes in a functional category and body size in Peto's paradox for cancer. ROYAL SOCIETY OPEN SCIENCE 2016; 3:160267. [PMID: 27703689 PMCID: PMC5043308 DOI: 10.1098/rsos.160267] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Accepted: 08/04/2016] [Indexed: 05/23/2023]
Abstract
Elucidation of tumour suppression mechanisms is a major challenge in cancer biology. Therefore, Peto's paradox, or low cancer incidence in large animals, has attracted focus. According to the gene-abundance hypothesis, which considers the increase/decrease in cancer-related genes with body size, researchers evaluated the associations between gene abundance and body size. However, previous studies only focused on a few specific gene functions and have ignored the alternative hypothesis (metabolic rate hypothesis): in this hypothesis, the cellular metabolic rate and subsequent oxidative stress decreases with increasing body size. In this study, we have elected to explore the gene-abundance hypothesis taking into account the metabolic rate hypothesis. Thus, we comprehensively investigated the correlation between the number of genes in various functional categories and body size while at the same time correcting for the mass-specific metabolic rate (Bc). A number of gene functions that correlated with body size were initially identified, but they were found to be artefactual due to the decrease in Bc with increasing body size. By contrast, immune system-related genes were found to increase with increasing body size when the correlation included this correction for Bc. These findings support the gene-abundance hypothesis and emphasize the importance of also taking into account the metabolic rate when evaluating gene abundance-body size relationships. This finding may be useful for understanding cancer evolution and tumour suppression mechanisms as well as for determining cancer-related genes and functions.
Collapse
Affiliation(s)
- Kazuhiro Takemoto
- Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan
| | - Masato Ii
- Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, Iizuka, Fukuoka 820-8502, Japan
| | - Satoshi S. Nishizuka
- Molecular Therapeutics Laboratory, Department of Surgery, Iwate Medical University School of Medicine, Morioka, Iwate 020-8505, Japan
| |
Collapse
|
41
|
Abstract
UNLABELLED Telomeres progressively shorten throughout life. A hallmark of advanced malignancies is the ability for continuous cell divisions that almost universally correlates with the stabilization of telomere length by the reactivation of telomerase. The repression of telomerase and shorter telomeres in humans may have evolved, in part, as an anticancer protection mechanism. Although there is still much we do not understand about the regulation of telomerase, it remains a very attractive and novel target for cancer therapeutics. This review focuses on the current state of advances in the telomerase area, identifies outstanding questions, and addresses areas and methods that need refinement. SIGNIFICANCE Despite many recent advances, telomerase remains a challenging target for cancer therapy. There are few telomerase-directed therapies, and many of the assays used to measure telomeres and telomerase have serious limitations. This review provides an overview of the current state of the field and how recent advances could affect future research and treatment approaches. Cancer Discov; 6(6); 584-93. ©2016 AACR.
Collapse
Affiliation(s)
- Jerry W Shay
- Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
| |
Collapse
|
42
|
Park JY, An YR, An CM, Kang JH, Kim EM, Kim H, Cho S, Kim J. Evolutionary constraints over microsatellite abundance in larger mammals as a potential mechanism against carcinogenic burden. Sci Rep 2016; 6:25246. [PMID: 27125812 PMCID: PMC4850439 DOI: 10.1038/srep25246] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2015] [Accepted: 04/08/2016] [Indexed: 12/29/2022] Open
Abstract
Larger organisms tend to live longer, have more potentially carcinogenic cells, and undergo more cell divisions. While one might intuitively expect cancer incidence to scale with body size, this assertion does not hold over the range of different mammals. Explaining this lack of correlation, so-called 'Peto's paradox' can likely increase our understanding of how cancer defense mechanisms are shaped by natural selection. Here, we study the occurrence of microsatellite in mammal genomes and observe that animals with expanded body size restrain the number of microsatellite. To take into account of higher mutation rate in the microsatellite region compared to that of genome, limiting the abundance of somatic mutations might explain how larger organisms could overcome the burden of cancer. These observations may serve as the basis to better understand how evolution has modeled protective mechanisms against cancer development.
Collapse
Affiliation(s)
- Jung Youn Park
- Biotechnology Research Division, National Fisheries Research & Development Institute, Gijang gun, Busan, 619-705, Republic of Korea
| | - Yong-Rock An
- Cetacean Research Institute, National Fisheries Research & Development Institute, Nam-gu, Ulsan 680-050, Republic of Korea
| | - Chul-Min An
- Biotechnology Research Division, National Fisheries Research & Development Institute, Gijang gun, Busan, 619-705, Republic of Korea
| | - Jung-Ha Kang
- Biotechnology Research Division, National Fisheries Research & Development Institute, Gijang gun, Busan, 619-705, Republic of Korea
| | - Eun Mi Kim
- Biotechnology Research Division, National Fisheries Research & Development Institute, Gijang gun, Busan, 619-705, Republic of Korea
| | - Heebal Kim
- Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Republic of Korea
- Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul 151-742, Republic of Korea
- C&K Genomics, Seoul National University Research Park, Seoul 151-919, Republic of Korea
| | - Seoae Cho
- C&K Genomics, Seoul National University Research Park, Seoul 151-919, Republic of Korea
| | - Jaemin Kim
- National Human Genome Research Institute, National Institutes of Health, Bethesda MD 20892, USA
| |
Collapse
|
43
|
Partridge L. Comments from the departing Editor. Philos Trans R Soc Lond B Biol Sci 2016; 371:20150471. [DOI: 10.1098/rstb.2015.0471] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
44
|
Nunney L. Commentary: The multistage model of carcinogenesis, Peto's paradox and evolution. Int J Epidemiol 2015; 45:649-53. [PMID: 26659656 DOI: 10.1093/ije/dyv201] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Affiliation(s)
- Leonard Nunney
- Department of Biology, University of California Riverside, Riverside, CA 92521, USA.
| |
Collapse
|